Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001
Immediate Surgery for Moyomoya Syndrome?
Arch Neurol 58:130-131,132, Roach,E.S., 2001
Surgery for Moyamoya Syndrome?
Arch Neurol 58:128-129,132, Scott,R.M., 2001
Circadian and Seasonal Occurrence of Subarachnoid and Intracerebral Hemorrhage
Neurol 56:190-193, Nyquist,P.A.,et al, 2001
Stroke Severity Determines Body Temperature in Acute Stroke
Stroke 32:413-417, Boysen,G. &Christensen,H., 2001
Recurrent Brain Hemorrhage is More Frequent Than Ischemic Stroke After Intracranial Hemorrhage
Neurol 56:773-777, Bailey,R.D.,et al, 2001
Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Timing of Spontaneous Recanalization and Risk of Hemorrhagic Transformation in Acute Cardioembolic Stroke
Stroke 32:1079-1084, Molina,C.A.,et al, 2001
Evolution of Cerebral Infarct Volume Assessed by Diffusion-Weighted Magnetic Resonance Imaging
Arch Neurol 58:613-617, Lansberg,M.,G.,et al, 2001
Prediction of Hemorrhagic Transformation Following Acute Stroke
Arch Neurol 58:587-593, Tong,D.C.,et al, 2001
Malpractice Claims: Outcome Evidence to Guide Neurologic Education?
Neurol 56:1099-1100,991, Glick,T.H., 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Inpatient Costs, Length of Stay, and Mortality for Cerebrovascular Events in Community Hospitals
Neurol 57:305-314, Reed,S.D.,et al, 2001
Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000
Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage
Stroke 31:2665-2669, Roob,G.,et al, 2000
Familial Occipital Calcifications, hemorrhagic Strokes, Leukoencephalopathy, Dementia, and External Carotid Dysplasia
Neurol 55:1661-1667, Iglesias,S.,et al, 2000
Stress-Related Primary Intracerebral Hemorrhage
Stroke 31:1426-1428, Lammie,G.A.,et al, 2000
Intracerebral Haemorrhage in Young Adults: The Emerging Importance of Drug Misuse
BMJ 320:1322-1324, McEvoy,A.W.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Motor Strokes Sparing the Leg
Arch Neurol 57:513-518, de Freitas,G.R.,et al, 2000
Deterioration of Giant Cell Arteritis With Corticosteroid Therapy
Arch Neurol 57:581-584, Staunton,H.,et al, 2000
Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke
JAMA 284:465-471, Perry,Jr.,H.M. et al, 2000
Management of Cerebellar Infarction With Mass Effect
The Neurologist 6:172-176, Koh, M. et al, 2000
Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000
Assessment of lacunar hemorrhage Associated With Hypertensive Stroke by Echo-Planar Gradient-Echo T2-Weighted MRI
Stroke 31:1646-1650, Kinoshita,T. et al, 2000
Seizures After Stroke
Arch Neurol 57:1617-1622, Bladin,C.F.,et al, 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
Rate of Stroke Recurrence in Patients with Primary Intracerebral Hemorrhage
Stroke 31:123-127, Hill,M.D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Identifying Stroke in the Field, Prospective Validation of the Los Angeles Prehospital Stroke Screen (LAPSS)
Stroke 31:71-76, Kidwell,C.S.,et al, 2000
Incidence and Prognostic Significance of Fever Following Intracerebral Hemorrhage
Neurol 54:354-361, Schwarz,S.,et al, 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Pure Sensory Stroke Caused by a Cerebral Hemorrhage: Clinical-Radiologic Correlations in Seven Patients
AJNR 21:515-520, Shintani,S.,et al, 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000
Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000
Carotid Endarterectomy after Recent Cerebral Infarction
Eur J Vasc Endovasc Surg 18:6-10, Hoffman,M.&Robbs,J., 1999
Major Bleeding During Anticoagulation after Cerebral Ischemia, Patterns and Risk Factors
Neurol 53:1319-1327, Gorter,J.W., 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Hemorrhage After an Acute Ischemic Stroke
Stroke 30:761-764, Motto,C.,et al, 1999
Ethnic Difference in Incidence of Stroke:Prospective Study with Stroke Register
BMJ 318:967-971, Stewart,J.A.,et al, 1999
Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999